Skip to main content

Senseonics Holdings Inc

For the period ended Mar 31, 2024. Filed May 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 13, 2024

SENS$9.80+14.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I: Financial Information​
​​
ITEM 1: Financial Statements​
​​
Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 20233
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended March 31, 2024 and 20234
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the three months ended March 31, 2024 and 20235
Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 20236
Notes to Unaudited Condensed Consolidated Financial Statements7
​​
ITEM 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations26
​​
ITEM 3: Quantitative and Qualitative Disclosures About Market Risk36
​​
ITEM 4: Controls and Procedures36
​​
PART II: Other Information37
​​
ITEM 1: Legal Proceedings37
​​
ITEM 1A: Risk Factors37
​​
ITEM 2: Unregistered Sales of Equity Securities and Use of Proceeds39
​​
ITEM 3: Defaults Upon Senior Securities39
​​
ITEM 4: Mine Safety Disclosures39
​​
ITEM 5: Other Information39
​​
ITEM 6: Exhibits40
​​
SIGNATURES41
​​

Condensed Consolidated Balance Sheet****s

(in thousands, except share and per share data)

​​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · ​ · 2024 · ​ · 2023 · ​
​​​(unaudited)​​​​
​​​​​​​​
Assets · ​ · ​ · ​ · ​ · ​
Current assets:​​​​​​​
Cash and cash equivalents​$90,544​$75,709​
Restricted cash​​316​​—​
Short term investments, net​​8,169​​33,747​
Accounts receivable, net​​1,001​​808​
Accounts receivable, net - related parties​​2,750​​3,724​
Inventory, net​​7,963​​8,776​
Prepaid expenses and other current assets​7,434​7,266​
Total current assets​118,177​130,030​
​​​​​​​​
Deposits and other assets​6,903​7,006​
Property and equipment, net​1,436​1,184​
Total assets​$126,516​$138,220​
Liabilities and Stockholders’ Equity​​​​​​​
Current liabilities:​​​​​​​
Accounts payable​$675​$4,568​
Accrued expenses and other current liabilities​10,034​11,744​
Accrued expenses and other current liabilities, related parties​​1,071​​945​
Note payable, current portion, net​​17,937​​—​
Derivative liability, current portion​​102​​—​
Total current liabilities​29,819​17,257​
​​​​​​​​
Long-term debt and notes payables, net​​33,965​​41,195​
Derivative liabilities​—​102​
Other liabilities​​6,114​​6,214​
Total liabilities​69,898​64,768​
​​​​​​​​
Preferred stock and additional paid-in-capital, subject to possible redemption: $0.001 par value per share; 12,000 shares and 12,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023​​37,656​​37,656​
Total temporary equity​​37,656​​37,656​
​​​​​​​​
Commitments and contingencies​​​​​​​
​​​​​​​​
Stockholders’ equity:​​​​​​​
Common stock, $0.001 par value per share; 900,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 530,817,549 shares and 530,364,237 shares issued and outstanding as of March 31, 2024 and December 31, 2023​530​530​
Additional paid-in capital​906,569​904,535​
Accumulated other comprehensive loss​​(2)​​(11)​
Accumulated deficit​(888,135)​(869,258)​
Total stockholders’ equity​18,962​35,796​
Total liabilities and stockholders’ equity​$126,516​$138,220​

Unaudited Condensed Consolidated Statements of Operations** and Comprehensive Income (Loss)**

(in thousands, except share and per share data)

​​​​​​​
​ · ​ · Three Months Ended
​ · ​ · March 31,
​ · 2024 · 2023
Revenue, net​$589​$313
Revenue, net - related parties​​4,458​​3,824
Total revenue​​5,047​​4,137
Cost of sales​​4,712​​3,723
Gross profit​​335​​414
​​​​​​​
Expenses:​​​​​​
Research and development expenses​​10,438​​12,405
Selling, general and administrative expenses​​8,129​7,718
Operating loss​​(18,232)​(19,709)
Other (expense) income, net:​​​​​​
Interest income​​1,384​​1,108
Exchange related gain, net​​—​​18,776
Interest expense​​(2,047)​​(4,652)
Gain on change in fair value of derivatives​​—​​5,778
Other income​​18​​23
Total other (expense) income, net​​(645)​​21,033
​​​​​​​
Net (Loss) Income​​(18,877)​​1,324
Other comprehensive income​​​​​​
Unrealized gain on marketable securities​​9​​458
Total other comprehensive gain​​9​​458
Total comprehensive (loss) income​$(18,868)​$1,782
​​​​​​​
Basic net (loss) income per common share​$(0.03)​$0.00
Basic weighted-average shares outstanding​​614,588,546​​497,473,222
​​​​​​​
Diluted net (loss) income per common share​$(0.03)​$0.00
Diluted weighted-average shares outstanding​​614,588,546​​540,532,813

**Unaudited Condensed Consolidated Statements of Changes in Stockholders’**Equity (Deficit)

** (in thousands)**

​​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · Additional · ​ · Accumulated · ​ · ​ · ​ · ​ · Total · ​ · Series B
​ · ​ · Common Stock · ​ · Paid-In · ​ · Other · ​ · Accumulated · ​ · Stockholders' · ​ · Convertible
​ · Shares · Amount · Capital · Comprehensive Loss · ​ · Deficit · ​ · Equity (Deficit) · Preferred Stock Temporary Equity
Three months ended March 31, 2023:​​​​​​​​​​​​​​​​​​​​
Balance, December 31, 2022479,637​$480​$806,488​$(678)​$(808,866)​$(2,576)​$37,656
Issuance of common stock, net of issuance costs​143​​—​​(65)​​—​​—​​(65)​​—
Exercise of stock options and warrants—​​—​​63,542​​—​​—​​63,542​​—
Stock-based compensation expense​—​​—​​1,781​​—​​—​​1,781​​—
Net income​—​​—​​—​​—​​1,324​​1,324​​—
Other comprehensive income, net of tax—​​—​​—​​458​​—​​458​​—
Balance, March 31, 2023479,780​$480​$871,746$(220)​$(807,542)​$64,464​$37,656
​​​​​​​​​​​​​​​​​​​​​
Three months ended March 31, 2024:​​​​​​​​​​​​​​​​​​​​
Balance, December 31, 2023​530,364​$530​$904,535​$(11)​$(869,258)​$35,796​$37,656
Issuance of common stock, net of issuance costs108​​—​​(1)​​—​​—​​(1)​​—
Issued common stock for vested RSUs and ESPP purchase​368​​—​​96​​—​​—​​96​​—
Issuance of warrants, net of issuance costs​—​​—​​149​​—​​—​​149​​—
Stock-based compensation expense​—​​—​​1,801​​—​​—​​1,801​​—
Shares withheld related to net share settlement of equity awards(22)​​—​​(11)​​—​​—​​(11)​​—
Net loss​—​​—​​—​​—​​(18,877)​​(18,877)​​—
Other comprehensive income, net of tax—​​—​​—​​9​​—​​9​​—
Balance, March 31, 2024530,818​$530​$906,569$(2)​$(888,135)​$18,962​$37,656
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.